daphnetoxin

RN given for (2S-(2alpha,3abeta,3bbeta,3cbeta,4abeta,5beta,5abeta,8aalpha,8balpha,9alpha,10abeta))-isomer; a PKCalpha activator; isolated from the bark of Daphne gnidium; structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 4 or More Rings Heterocyclic Compounds
    - daphnetoxin: 2

Experts

1.	Chen, Calvin Yu-Chian: 1 article (01/2014)
2.	Chen, Kuen-Bao: 1 article (01/2014)
3.	Lee, Cheng-Chun: 1 article (01/2014)
4.	Lee, Wen-Yuan: 1 article (01/2014)
5.	Liao, Kai Hsin: 1 article (01/2014)
6.	Sun, Mao-Feng: 1 article (01/2014)
7.	Barbosa, Inês A: 1 article (08/2009)
8.	Burgeiro, Ana: 1 article (08/2009)
9.	Carvalho, Maria J M: 1 article (08/2009)
10.	Diogo, Cátia V: 1 article (08/2009)

Related Diseases

1.	Neoplasms (Cancer) 08/01/2009 - "Mitochondrial toxicity of the phyotochemicals daphnetoxin and daphnoretin--relevance for possible anti-cancer application."
2.	Alzheimer Disease (Alzheimer's Disease) 01/01/2014 - "Our results indicate that Daphnetoxin, 20-O-(2'E,4'E-decadienoyl)ingenol, and Lythrancine II may be starting points for further modification as a new type of non-amyloid-beta-centric drug for Alzheimer's disease. "

Related Drugs and Biologics

1.	Amyloid beta-Peptides
2.	daphnoretin